Mapping of hormones and cortisol responses in patients after Lyme neuroborreliosis

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Tjernberg, Ivar ^a,b   Carlsson, Martin ^a   Ernerudh, Jan ^b   Eliasson, Ingvar ^c   Forsberg, Pia ^b  

^a KALMAR COUNTY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c Department of Clinical and Experimental Medicine Linköping University ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CEFTRIAXONE; CORTICOTROPIN; DOXYCYCLINE; HYDROCORTISONE; INTERLEUKIN 6; TETRACOSACTIDE; ADRENOCORTICOTROPIN ZINC; BACTERIUM ANTIBODY;

ABSENCE OF SIDE EFFECTS; ANTHROPOMETRY; ARTICLE; BRAIN MAPPING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; DRUG RESPONSE; ENDOCRINE FUNCTION TEST; HORMONE RESPONSE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LYME DISEASE; SYMPTOMATOLOGY; TREATMENT DURATION; ADULT; AGED; BLOOD; CASE CONTROL STUDY; FEMALE; MALE; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; COSYNTROPIN; FEMALE; HUMANS; HYDROCORTISONE; INTERLEUKIN-6; LYME NEUROBORRELIOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77249147969     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-20     Document Type: Article

References (31)

1. Stanek G, Strle F. Lyme borreliosis. Lancet 2003, 362(9396):1639-1647. 10.1016/S0140-6736(03)14798-8, 14630446.
2. Berglund J, Eitrem R, Ornstein K, Lindberg A, Ringer A, Elmrud H, Carlsson M, Runehagen A, Svanborg C, Norrby R. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 1995, 333(20):1319-1327. 10.1056/NEJM199511163332004, 7566023.
3. Berglund J, Stjernberg L, Ornstein K, Tykesson-Joelsson K, Walter H. 5-y Follow-up study of patients with neuroborreliosis. Scand J Infect Dis 2002, 34(6):421-425. 10.1080/00365540110080421, 12160168.
4. Treib J, Fernandez A, Haass A, Grauer MT, Holzer G, Woessner R. Clinical and serologic follow-up in patients with neuroborreliosis. Neurology 1998, 51(5):1489-1491.
5. Vrethem M, Hellblom L, Widlund M, Ahl M, Danielsson O, Ernerudh J, Forsberg P. Chronic symptoms are common in patients with neuroborreliosis -- a questionnaire follow-up study. Acta Neurol Scand 2002, 106(4):205-208. 10.1034/j.1600-0404.2002.01358.x, 12225315.
6. Pfister HW, Rupprecht TA. Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients. Int J Med Microbiol 2006, 296(Suppl 40):11-16. 10.1016/j.ijmm.2005.12.003, 16524775.
7. Steiner I. Treating post Lyme disease: trying to solve one equation with too many unknowns. Neurology 2003, 60(12):1888-1889.
8. Brooks MH, Dumlao JS, Bronsky D, Waldstein SS. Hypophysial tuberculoma with hypopituitarism. Am J Med 1973, 54(6):777-781. 10.1016/0002-9343(73)90065-X, 4705420.
9. Hagg E, Astrom L, Steen L. Persistent hypothalamic-pituitary insufficiency following acute meningoencephalitis. A report of two cases. Acta Med Scand 1978, 203(3):231-235.
10. Haslam RH, Winternitz WW, Howieson J. Selective hypopituitarism following tuberculous menigitis. Am J Dis Child 1969, 118(6):903-908.
11. Ickenstein GW, Klotz JM, Langohr HD. [Virus encephalitis with symptomatic Parkinson syndrome, diabetes insipidus and panhypopituitarism]. Fortschr Neurol Psychiatr 1999, 67(10):476-481. 10.1055/s-2007-994998, 10596369.
12. Jew K, Piziak V, Gilliland PF, Hurley DL. Meningoencephalitis complicated by pituitary insufficiency and a spontaneously resolving suprasellar mass. Neurosurgery 1984, 14(5):567-569. 10.1097/00006123-198405000-00008, 6728163.
13. Kupari M, Pelkonen R, Valtonen V. Post-encephalitic hypothalamic-pituitary insufficiency. Acta Endocrinol (Copenh) 1980, 94(4):433-438.
14. Lichtenstein MJ, Tilley WS, Sandler MP. The syndrome of hypothalamic hypopituitarism complicating viral meningoencephalitis. J Endocrinol Invest 1982, 5(2):111-115.
15. Summers VK, Hipkin LJ, Osborne Hughes R, Davis JC. Panhypopituitarism after cured tuberculous meningitis. Br Med J 1968, 1(5588):359. 10.1136/bmj.1.5588.359, 1984892, 15508206.
16. Vesely DL, Mastrandrea P, Samson C, Argyelan G, Charvit S. Post-herpes encephalitic anterior pituitary insufficiency with hypothermia and hypotension. Am J Med Sci 2000, 320(4):273-277. 10.1097/00000441-200010000-00008, 11061353.
17. Mastorakos G, Chrousos GP, Weber JS. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 1993, 77(6):1690-1694. 10.1210/jc.77.6.1690, 8263159.
18. Zarkovic M, Ignjatovic S, Dajak M, Ciric J, Beleslin B, Savic S, Stojkovic M, Bulat P, Trbojevic B. Cortisol response to ACTH stimulation correlates with blood interleukin 6 concentration in healthy humans. Eur J Endocrinol 2008, 159(5):649-652. 10.1530/EJE-08-0544, 18753312.
19. Schaefer S, Boegershausen N, Meyer S, Ivan D, Schepelmann K, Kann PH. Hypothalamic-pituitary insufficiency following infectious diseases of the central nervous system. Eur J Endocrinol 2008, 158(1):3-9. 10.1530/EJE-07-0484, 18166811.
20. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 2003, 78(12):1463-1470. 10.4065/78.12.1463, 14661675.
21. Musselman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S, Pearce BD, Landry J, Glover S, McDaniel JS, et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 2001, 158(8):1252-1257. 10.1176/appi.ajp.158.8.1252, 11481159.
22. Sjogren E, Leanderson P, Kristenson M, Ernerudh J. Interleukin-6 levels in relation to psychosocial factors: studies on serum, saliva, and in vitro production by blood mononuclear cells. Brain Behav Immun 2006, 20(3):270-278. 10.1016/j.bbi.2005.08.001, 16183246.
23. Zautra AJ, Yocum DC, Villanueva I, Smith B, Davis MC, Attrep J, Irwin M. Immune activation and depression in women with rheumatoid arthritis. J Rheumatol 2004, 31(3):457-463.
24. Amsterdam JD, Winokur A, Abelman E, Lucki I, Rickels K. Cosyntropin (ACTH alpha 1-24) stimulation test in depressed patients and healthy subjects. Am J Psychiatry 1983, 140(7):907-909.
25. Jaeckle RS, Kathol RG, Lopez JF, Meller WH, Krummel SJ. Enhanced adrenal sensitivity to exogenous cosyntropin (ACTH alpha 1-24) stimulation in major depression. Relationship to dexamethasone suppression test results. Arch Gen Psychiatry 1987, 44(3):233-240.
26. Shimoda K, Yamada N, Hanada K, Tsujimoto T, Takahashi S, Takahashi K. Morning and evening adrenocortical responses to ACTH stimulation in endogenously depressed patients: a preliminary report. Jpn J Psychiatry Neurol 1989, 43(1):57-62.
27. Amsterdam JD, Maislin G, Abelman E, Berwish N, Winokur A. Adrenocortical responsiveness to the ACTH stimulation test in depressed patients and healthy volunteers. J Affect Disord 1986, 11(3):265-274. 10.1016/0165-0327(86)90078-9, 3031145.
28. Rubin RT, Miller TH, Rhodes ME, Czambel RK. Adrenal cortical responses to low- and high-dose ACTH(1-24) administration in major depressives vs. matched controls. Psychiatry Res 2006, 143(1):43-50. 10.1016/j.psychres.2005.10.003, 16707164.
29. Rubin RT, Phillips JJ, Sadow TF, McCracken JT. Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment. Arch Gen Psychiatry 1995, 52(3):213-218.
30. Thakore JH, Barnes C, Joyce J, Medbak S, Dinan TG. Effects of antidepressant treatment on corticotropin-induced cortisol responses in patients with melancholic depression. Psychiatry Res 1997, 73(1-2):27-32. 10.1016/S0165-1781(97)00106-6, 9463836.
31. Armario A. The hypothalamic-pituitary-adrenal axis: what can it tell us about stressors?. CNS Neurol Disord Drug Targets 2006, 5(5):485-501. 10.2174/187152706778559336, 17073652.